BeloorBayir Biotech

What BeloorBayir Biotech does

BeloorBayir Biotech Limited is a privately held, vertically integrated pharmaceutical and nutraceutical manufacturer founded in 1981 in Bangalore, India, by B.G. Bairy. The company manufactures and markets active pharmaceutical ingredients (APIs), nutraceutical ingredients, and botanical extracts, serving pharmaceutical finished-dose manufacturers, nutraceutical and supplement brands, and Ayurvedic product companies. Reported exports span more than 30 countries, with Drug Master Files registered in over 35 jurisdictions. Core product groups include Glucosamine variants, Minoxidil, Donepezil, Chondroitin, L-Carnitine, CoQ10, Papain, and Serratiopeptidase on the API side, and Garcinia, Curcumin 95%, Green Tea 90%, Ashwagandha, Boswellia, Bacopa, Yohimbine, and Nano Curcumin in the botanical extracts portfolio. Manufacturing capacity reached 240+ metric tonnes of glucosamine and 300+ metric tonnes of botanical extracts by 2008, supported by 125+ AYUSH-licensed formulations and 30+ therapeutic agents in the pipeline.

The company operates seven state-of-the-art manufacturing facilities across Bangalore, Tumkur, Bidadi, Bhatkal, Hyderabad, and Pune, and holds an unusually broad stack of international certifications, including WHO cGMP, EU GMP, NSF, AYUSH, FSSAI, ISO 9001:2008, ISO 22000:2005, HALAL, KOSHER, ANVISA (Brazil), COFEPRIS (Mexico), and BGV Hamburg GMP. Its R&D laboratory is recognized by the Department of Scientific and Industrial Research (DSIR), India, with capabilities spanning hydrogenation, halogenation, Grignard reactions, chiral synthesis, catalytic transfer hydrogenation, butyl lithium chemistry, high-pressure reactions, and biofermentation. The firm has stated an intent to position most future products on a proprietary nanotechnology platform that redefines dosage forms and bioavailability, with nanoparticle-based launches in 2016 already reportedly contributing 30% of sales turnover.

Revenue is generated through B2B bulk ingredient sales (APIs and nutraceutical ingredients), private-label formulation contract manufacturing (tablets, capsules, soft-gels, ointments, liquids, creams) via a 90,000 sq. ft. dedicated facility, and two ethical marketing divisions, Cardia (pharmaceuticals) and Sneha Natura (Ayurvedic products), which market the company's own portfolio. Distribution relies on direct enterprise sales across 30+ countries, with the only named enterprise customer reference being the Balsara Group, which was the largest client at the company's founding in 1981. Headcount sits in the 501-1000 range, and leadership comprises founder B.G. Bairy (Chairman and Managing Director), Ajay Bairy (Executive Director and Head of Operations, joined 2013), and N. Srinivasan as CFO. In March 2014, the company raised $12.4 million from Rabo Equity Advisors, its first identified institutional capital round.

Name

BeloorBayir Biotech

Legal name

Beloorbayir Biotech Limited

Website

https://beloorbayir.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BeloorBayir Biotech Limited is a Bangalore-based, privately held manufacturer of active pharmaceutical ingredients, nutraceutical ingredients, and botanical extracts, serving pharmaceutical, nutraceutical, and Ayurvedic manufacturers in 30+ countries via seven certified facilities.

Ownership category

akta.pro rank

Product category

Pharmaceutical API Manufacturing

NAICS

Fruit and Vegetable Preserving and Specialty Food Manufacturing (3114), Chemical and Allied Products Merchant Wholesalers (4246)

SIC

Industrial Organic Chemicals (2860), Food And Kindred Products (2000)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

akta.pro secondary industries

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ)

Keywords

• Active pharmaceutical ingredients
• Botanical extracts manufacturing
• Nutraceutical ingredients supply
• Private label formulations
• Ayurvedic product manufacturing

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredients (API) Manufacturing: Manufacturing and marketing of select active pharmaceutical ingredients to more than 30 countries
2. Botanical Extracts: Manufacturing and supply of botanical/herbal extracts from wild and cultivated pesticide-free sources
3. Nutraceutical Ingredients: Manufacturing and marketing of nutraceutical ingredients including glucosamine and related compounds
4. Private Label Formulations: Private label formulation manufacturing for Ayurvedic products and nutraceutical finished products

Go-to-market motion2 records

Distribution channels4 records

Marketing channels2 records

Core offering

BeloorBayir Biotech is a vertically integrated manufacturer and global supplier of Active Pharmaceutical Ingredients (APIs), nutraceutical ingredients, and botanical/herbal extracts. The company also offers private-label formulation manufacturing covering tablets, capsules, soft-gels, ointments, liquids, and creams for Ayurvedic and nutraceutical brands, supported by two ethical marketing divisions — Cardia (pharmaceuticals) and Sneha Natura (Ayurvedic/nutraceutical).

Product overview

BeloorBayir Biotech is a vertically integrated pharmaceutical and nutraceutical company offering a broad portfolio of Active Pharmaceutical Ingredients (API), Botanical/Herbal Extracts, Ayurvedic products, and private-label formulation manufacturing services. The core products include Minoxidil and Glucosamine variants (API), and botanical extracts such as Garcinia, Green Tea, Curcumin, and Nano Curcumin. These are complemented by sub-brands Cardia (pharmaceutical marketing) and Sneha Natura (Ayurvedic/nutraceutical marketing), along with formulation development and regulatory affairs services. The company operates 7 state-of-the-art manufacturing facilities across India and exports to over 30 countries, with R&D recognized by DSIR India and a pipeline of 30+ therapeutic agents.

Differentiator

Problem solved

Functional benefit

Brands

• Cardia: Ethical marketing division covering pharmaceutical products
• Sneha Natura

Products and services

• Active Pharmaceutical Ingredients (APIs) Broad portfolio of cGMP-manufactured APIs (Minoxidil, Glucosamine variants, Donepezil, Chondroitin, L-Carnitine variants, Co Enzyme Q10, Papain, Serratiopeptidase, etc.) supplied to pharmaceutical finished-dosage manufacturers in more than 30 countries.
• Botanical Extracts Standardized natural extracts including Garcinia variants, Green Tea 90%, Curcumin 95%, Nano Curcumin, Senna, Gymnema, Yohimbine 98%, Ashwagandha, Bacopa, Boswellia, and 30+ other herbal extracts sourced from wild and cultivated pesticide-free sources, supplied to nutraceutical and supplement manufacturers globally.
• Ayurvedic & Nutraceutical Private Label Formulations Contract / private-label manufacturing services for Ayurvedic and nutraceutical finished products, covering tablets, capsules, soft-gels, ointments, liquids, and creams, leveraging 125+ AYUSH-licensed formulations.
• Sneha Natura — Ethical Marketing Division for Ayurvedic & Nutraceutical Products Wholly owned ethical marketing division of Beloorbayir Biotech that markets Ayurvedic and nutraceutical ingredients/products under the Sneha Natura brand (snehanatura.com).
• Bayir Inc — Pharmaceutical & Biotech Vertical Wholly owned business vertical (bayirinc.com) focusing on pharmaceutical and biotech products, including the company's nanoparticle-based ingredients and API offerings.
• Formulation Development Services R&D and formulation development services — both self-initiated and partner-financed — covering synthetic API process development, natural botanical active-substance development, process contract research, and finished dosage formulation development.
• Regulatory Affairs Services Professional regulatory affairs services covering licensing and registration of food businesses, packaging and labeling per international regulations, food product standards, and import/export compliance across multiple jurisdictions.
• Quality Compliance Services Quality assurance services maintaining pharmaceutical cGMP functions through QMS, TQM, training, and effective documentation with traceability, implemented via SAP-based systems.

Quantifiable outcome

• Nanotechnology-based products expected to constitute 30% of overall sales turnover

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Academic InstitutionscoreStrategic or Co-development PartnerBeloorbayir is a proud leader in Academia-Industry partnerships, committed to bringing great minds together to help solve tough chemical & biotechnological challenges. Collaborations accelerate breakthroughs for customers and increase efficiency of bringing new active substances to market.

Scale indicators9 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Divi's Laboratories: Large Indian API manufacturer with global exports; the closest India-headquartered peer for BeloorBayir's pharmaceutical API business (e.g., glucosamine intermediates).
• Sabinsa: Indian-headquartered manufacturer of standardized botanical extracts and nutraceutical ingredients with a global B2B customer base; BeloorBayir competes head-to-head on curcumin, garcinia, and other phytochemicals.
• OmniActive Health Technologies: India-based ingredient supplier of carotenoids, curcuminoids and plant-based nutraceuticals serving global dietary supplement brands; overlaps BeloorBayir's botanical extraction business.
• Arjuna Natural: Indian manufacturer of herbal extracts and nutraceutical ingredients (BCM-95 turmeric, Amlamax, etc.) with strong export presence; directly comparable botanical-extract portfolio.
• Martin Bauer Group: German-headquartered provider of botanical extracts, flavors and functional ingredients; analogous B2B extract and formulation manufacturer with multi-decade heritage.
• Indena: Italian-headquartered producer of botanical extracts and high-purity APIs for pharma and nutraceutical customers; similar vertically integrated extraction-and-API model.
• Gencor: Global ingredient supplier specializing in branded, science-backed botanical extracts for the nutraceutical industry; directly competing product portfolio and channel.

Broad incumbents

• Aurobindo Pharma: Large Indian pharmaceutical company with significant API, generics and nutraceutical operations; broader scope but overlapping APIs and global distribution channels.
• Kerry Group: Global taste and nutrition ingredients supplier serving food, beverage and nutraceutical manufacturers; relevant overlap on specialty ingredients and formulation services.
• Chr. Hansen: Diversified bioscience company supplying cultures, enzymes and natural ingredient solutions to food and supplement producers; broader portfolio but adjacent customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/beloor_bayir
• Facebookfacebook.com/100014013151791
• LinkedInlinkedin.com/company/beloorbayir

Compliance15 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BeloorBayir Biotech